- India
- /
- Personal Products
- /
- NSEI:COLPAL
It Might Not Be A Great Idea To Buy Colgate-Palmolive (India) Limited (NSE:COLPAL) For Its Next Dividend
Readers hoping to buy Colgate-Palmolive (India) Limited (NSE:COLPAL) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is two business days before a company's record date in most cases, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. This means that investors who purchase Colgate-Palmolive (India)'s shares on or after the 28th of May will not receive the dividend, which will be paid on the 20th of June.
The company's next dividend payment will be ₹27.00 per share. Last year, in total, the company distributed ₹51.00 to shareholders. Based on the last year's worth of payments, Colgate-Palmolive (India) stock has a trailing yield of around 2.1% on the current share price of ₹2479.40. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
Our free stock report includes 1 warning sign investors should be aware of before investing in Colgate-Palmolive (India). Read for free now.Dividends are usually paid out of company profits, so if a company pays out more than it earned then its dividend is usually at greater risk of being cut. Last year, Colgate-Palmolive (India) paid out 97% of its income as dividends, which is above a level that we're comfortable with, especially if the company needs to reinvest in its business. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. Over the past year it paid out 123% of its free cash flow as dividends, which is uncomfortably high. It's hard to consistently pay out more cash than you generate without either borrowing or using company cash, so we'd wonder how the company justifies this payout level.
As Colgate-Palmolive (India)'s dividend was not well covered by either earnings or cash flow, we would be concerned that this dividend could be at risk over the long term.
Check out our latest analysis for Colgate-Palmolive (India)
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
Have Earnings And Dividends Been Growing?
Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. For this reason, we're glad to see Colgate-Palmolive (India)'s earnings per share have risen 12% per annum over the last five years. We're a bit put out by the fact that Colgate-Palmolive (India) paid out virtually all of its earnings and cashflow as dividends over the last year. Earnings are growing at a decent clip, so this payout ratio may prove sustainable, but it's not great to see.
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Colgate-Palmolive (India) has delivered 15% dividend growth per year on average over the past 10 years. It's great to see earnings per share growing rapidly over several years, and dividends per share growing right along with it.
Final Takeaway
From a dividend perspective, should investors buy or avoid Colgate-Palmolive (India)? While it's nice to see earnings per share growing, we're curious about how Colgate-Palmolive (India) intends to continue growing, or maintain the dividend in a downturn given that it's paying out such a high percentage of its earnings and cashflow. Bottom line: Colgate-Palmolive (India) has some unfortunate characteristics that we think could lead to sub-optimal outcomes for dividend investors.
With that being said, if you're still considering Colgate-Palmolive (India) as an investment, you'll find it beneficial to know what risks this stock is facing. Our analysis shows 1 warning sign for Colgate-Palmolive (India) and you should be aware of this before buying any shares.
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:COLPAL
Colgate-Palmolive (India)
Manufactures and trades in personal and oral care products in India.
Flawless balance sheet with proven track record.
Similar Companies
Market Insights
Community Narratives


